Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Vertex Europe (UK) — Right-of-use lease assets by Year
Vertex Europe (UK) — Right-of-use lease assets ($M) ($M)
Vertex Pharmaceuticals Vertex Europe (UK) — Right-of-use lease assets: $115M in FY2025, down 11.2% from a year earlier.
Where the FY2025 figure comes from
“Right-of-use assets 20 114,892 129,388”
Source: Vertex Pharmaceuticals (Europe) Limited (02907620) ↗
Reported in UK Companies House Statutory Accounts (02907620, OCR).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Vertex Europe (UK) — Right-of-use lease assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 115 | -11.2% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2024 | Dec 31, 2024 | 129 | +310.8% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2023 | Dec 31, 2023 | 31.5 | -14.4% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2022 | Dec 31, 2022 | 36.8 | +89.7% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2021 | Dec 31, 2021 | 19.4 | -16.4% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2020 | Dec 31, 2020 | 23.2 | -8.7% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2019 | Dec 31, 2019 | 25.4 | – | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Vertex Europe (UK) — Right-of-use lease assets ($M), annual FY2019–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/uk-eur-rou-assets
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.